LR
Larimar Therapeutics, Inc.
LRMR · NASDAQ
$3.79 +0.26% (+$0.01)
1M -9.33%
Market Cap $394.8M
P/E Ratio -
Div. Yield -
ROE 137.39%
Bulios Fair Price
$2.62
30.9% downside
Trenutna cena
$3.79
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica LRMR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
65 /100
Fair P/B 3.10x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 11.04%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 135.25%
ROE 137.39%
ROA 104.42%
Debt
100 /100
Low Debt/Equity 0.04x
Current ratio 4.70x
Int. coverage N/A
Stability
48 /100
Moderate Beta 0.75x
EPS volatility 59.01%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o LRMR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Carole S. Ben-Maimon
Employees
71
Headquarters
Bala Cynwyd
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report